Astrazeneca AZN
NYSE AZN
$171.47 -1.13 (-0.65%)
At close: Oct 23, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Astrazeneca (AZN) posted Return on Invested Capital [ROIC] of 28.83% for Q2 2026, up 4.16 percentage points from 24.67% a year earlier but down 0.46 percentage points from the prior quarter.

Analysis

Astrazeneca (AZN) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Astrazeneca's Return on Invested Capital [ROIC] came in at 30.05%, up 4.67 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has increased for four consecutive years, though with a five-year change of -5.23 percentage points (FY2020 to FY2025).
  • In prior years, Astrazeneca's Return on Invested Capital [ROIC] was 25.38% in FY2024 (+3.50 pp), 21.87% in FY2023 (+15.05 pp), 6.83% in FY2022 (+2.89 pp) and 3.93% in FY2021 (-31.35 pp).
  • Quarterly Return on Invested Capital [ROIC] has run from a low of -1.54% in Q2 2022 to a high of 29.28% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has increased in each of the last seven quarters, with an average year-over-year change of +2.40 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Invested Capital [ROIC] in the past five years was Q3 2023, with a gain of 22.70 percentage points; the weakest was Q1 2022, with a drop of 40.44 percentage points.
  • According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was 29.28% (Q1 2026), 28.51% (Q4 2025) and 26.52% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Vertex Pharmaceuticals 132.74 Bn 104.74 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.26%
Mar 31, 2026 24.60%
Dec 31, 2025 24.73%
Sep 30, 2025 23.32%
Jun 30, 2025 19.80%
Mar 31, 2025 19.58%
Dec 31, 2024 18.15%
Sep 30, 2024 16.40%
Jun 30, 2024 17.48%
Mar 31, 2024 17.84%
Dec 31, 2023 16.50%
Sep 30, 2023 16.31%
Jun 30, 2023 13.20%
Mar 31, 2023 10.33%
Dec 31, 2022 6.12%
Sep 30, 2022 1.66%
Jun 30, 2022 -1.11%
Mar 31, 2022 0.08%
Dec 31, 2021 2.01%
Sep 30, 2021 5.51%
API Access

Astrazeneca Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY